Infusion Therapy

We use Inflectra (infliximab, also known as Remicade®) for the treatment and maintenance of:

• Remission of moderately to severely active Crohn’s disease
• Ulcerative colitis that doesn’t respond to conventional therapy
• Fistulizing Crohn’s disease (fistulas are abnormal channels between two loops of intestine or between the intestine and another structure, such as the skin)

Adults and children over 6 can receive Inflectra therapy. Infusions take about two hours to complete, and you’ll likely receive them every eight weeks.

We use Entyvio (vedolizumab) to treat adults with moderate to severe Crohn’s disease and ulcerative colitis. Entyvio works by preventing too many white blood cells from entering the gastrointestinal (GI) tract, which can lower chronic inflammation.

You’ll receive your Entyvio infusion over about 30 minutes. Your doctor will monitor you during and after your infusion treatment to watch for any potential side effects.

We use Tysabri (natalizumab) to induce and maintain remission in adults with moderate to severe Crohn’s disease. If you have evidence of inflammation and either don’t respond well to conventional treatments or can’t tolerate them, your doctor may recommend Tysabri therapy.

You’ll receive an infusion of Tysabri every four weeks. It will take an hour for you to receive your infusion.